Cyclocarya paliurus extract alleviates diabetic nephropathy by inhibiting oxidative stress and aldose reductase

References

• Valk EJJ, Bruijn JA, Bajema IM. Diabetic nephropathy in humans: Pathologic diversity. Curr Opin Nephrol Hypertens. 2011;20:285–289.
   PubMed Web of Science ®Google Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–1070.
   PubMed Web of Science ®Google Scholar
• Feng B, Ruiz M, Chakrabarti S. Oxidative-stress-induced epigenetic changes in chronic diabetic complications. Can J Physiol Pharmacol. 2013;91:213–220.
   PubMed Web of Science ®Google Scholar
• Jang S, Kim M, Choi M, Kwon E, Lee M. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice. Metab Clin Exp. 2010;59:512–519.
   PubMed Web of Science ®Google Scholar
• Schemmel K, Padiyara R, Souza J. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review. J Diabetes Complications. 2010;24:354–360.
   PubMed Web of Science ®Google Scholar
• Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, Demopoulos V. Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem. 2009;16:734–752.
   PubMed Web of Science ®Google Scholar
• Srivastava S, Ramana K, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev. 2005;26:380–392.
   PubMed Web of Science ®Google Scholar
• Yang H, Chen S, Lin K, Wang MT, Chen YC, Huang HC, Cho HJ, et al. Antioxidant activities of aqueous leaf extracts of Toona sinensis on free radical-induced endothelial cell damage. J Ethnopharmacol. 2011;7:669–680.
   Web of Science ®Google Scholar
• Ren M, Yang S, Li J, Hu Y, Ren Z, Ren S. Ginkgo biloba L. extract enhances the effectiveness of syngeneic bone marrow mesenchymal stem cells in lowering blood glucose levels and reversing oxidative stress. Endocrine. 2013;43:360–369.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim KM, Kim CS, Sohn E, Lee YM, Jo K, Kim JS. Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress. Free Radic Biol Med. 2012;53:357–365.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Jiang CH, Fang SZ, Wang J, Ji Y, Shang X, Ni Y, et al. Antihyperglycemic, antihyperlipidemic and antioxidant effects of ethanol and aqueous extracts of Cyclocarya paliurus leaves in type 2 diabetic rats. J Ethnopharmacol. 2013;150:1119–1127.
   PubMed Web of Science ®Google Scholar
• Xie JH, Liu X, Shen MY, Nie SP, Zhang H, Li C, Gong DM, Xie MY. Purification, physicochemical characterisation and anticancer activity of a polysaccharide from Cyclocarya paliurus leaves. Food Chem. 2013;136:1453–1460.
   PubMed Web of Science ®Google Scholar
• Kurihara H, Asami S, Shibata H, Fukami H, Tanaka T. Hypolipemic effect of Cyclocarya paliurus (Batal) Iljinskaja in lipid-loaded mice. Biol Pharm Bull. 2003;26:383–385.
   PubMed Web of Science ®Google Scholar
• Xie JH, Liu X, Shen MY, Nie SP, Zhang H, Li C, Gong DM, Xie MY. Ultrasonic-assisted extraction, antimicrobial and antioxidant activities of Cyclocarya paliurus (Batal.) Iljinskaja polysaccharides. Carbohydr Polym. 2012;89:177–184.
   PubMed Web of Science ®Google Scholar
• Fu R, Zhang YT, Guo YR, Huang QL, Peng T, Xu Y, Tang L, Chen F. Antioxidant and anti-inflammatory activities of the phenolic extracts of Sapium sebiferum (L.) Roxb. leaves. J Ethnopharmacol. 2013;147:517–524.
   PubMed Web of Science ®Google Scholar
• Chung YS, Choi YH, Lee SJ, Choi SA, Lee JH, Kim H, Hong EK Water extract of Aralia elata prevents cataractogenesis in vitro and in vivo. J Ethnopharmacol. 2005;101:49–54.
   PubMed Web of Science ®Google Scholar
• Li C, Ng K, Shao Y , Liu XB, Ling CC, Ma YY, Geng W, et al. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response. Ann Surg. 2014;260:317–328.
   PubMed Web of Science ®Google Scholar
• Kumar R, Patel D, Laloo D, Sairam K, Hemalatha S. Inhibitory effect of two Indian medicinal plants on aldose reductase of rat lens in vitro. Asian Pac J Trop Med. 2011;4:694–697.
   PubMed Web of Science ®Google Scholar
• Manna P, Sinha M, Sil P. Prophylactic role of arjunolic acid in response to streptozotocin mediated diabetic renal injury: Activation of polyol pathway and oxidative stress responsive signaling cascades. Chem Biol Interact. 2009;181:297–308.
   PubMed Web of Science ®Google Scholar
• Jeon YL, Kim MH, Lee WI, Kang SY. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes. Clin Lab. 2013;59:1221–1229.
   PubMed Web of Science ®Google Scholar
• Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1? Adv Med Sci. 2013;58:353–361.
   PubMed Web of Science ®Google Scholar
• Sun Q, Shen ZY, Meng QT, Liu HZ, Duan WN, Xia ZY. The role of DJ-1/Nrf2 pathway in the pathogenesis of diabetic nephropathy in rats. Ren Fail. 38(2):294–304.
   PubMedGoogle Scholar
• Žeravica R, Čabarkapa V, Ilinčić B, Sakač V, Mijović R, Nikolić S, Stošić Z. Plasma endothelin-1 level, measured glomerular filtration rate and effective renal plasma flow in diabetic nephropathy. Ren Fail. 2015;37:681–686.
   PubMed Web of Science ®Google Scholar
• Zanatta CM, Veronese FV, Loreto MS, Sortica DA, Carpio VN, Eldeweiss MI, da Silva VD, et al. Endothelin-1 and endothelin a receptor immunoreactivity is increased in patients with diabetic nephropathy. Ren Fail. 2012;34:308–315.
   PubMed Web of Science ®Google Scholar
• Svensson MK, Eriksson JW. Change in the amount of body fat and IL-6 levels is related to altered insulin sensitivity in type 1 diabetes patients with or without diabetic nephropathy. Horm Metab Res. 2011;43:209–215.
   PubMed Web of Science ®Google Scholar
• Perlman AS, Chevalier JM, Wilkinson P, Liu H, Parker T, Levine DM, Sloan BJ, et al. Serum inflammatory and immune mediators are elevated in early stage diabetic nephropathy. Ann Clin Lab Sci. 2015;45:256–263.
   PubMed Web of Science ®Google Scholar
• Dimas G, Iliadis F, Tegos T, Spiroglou S, Kanellos I, Karamouzis I, Savopoulos C, et al. Serum levels of timp-1 and IL-6 are associated with hypertension and atherosclerosis in patients with early stages of chronic kidney disease and type 2 diabetic nephropathy. J Hypertens. 2015;33:e55.
   PubMedGoogle Scholar
• Arora MK, Singh UK. Oxidative stress: Meeting multiple targets in pathogenesis of diabetic nephropathy. Curr Drug Targets. 2014;15:531–538.
   PubMed Web of Science ®Google Scholar
• Sadi G, Güray T. Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: Effect of antioxidants. Mol Cell Biochem. 2009;327:127–134.
   PubMed Web of Science ®Google Scholar
• Hou S, Zheng F, Li Y, Gao L, Zhang J. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose. Int J Mol Sci. 2014;15:15026–15043.
   PubMed Web of Science ®Google Scholar
• Tang DQ, Wei YQ, Gao YY, Yin XX, Yang DZ, Mou J, Jiang XL. Protective effects of rutin on rat glomerular mesangial cells cultured in high glucose conditions. Phytother Res. 2011;25:1640–1647.
   PubMed Web of Science ®Google Scholar
• Hong SH, Lee HJ, Sohn EJ, Ko HS, Shim BS, Ahn KS, Kim SH. Anti-nephrolithic potential of resveratrol via inhibition of ROS, MCP-1, hyaluronan and osteopontin in vitro and in vivo. Pharmacol Rep. 2013;65:970–979.
   PubMed Web of Science ®Google Scholar